ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

ORI Finds Misconduct By Two Researchers

December 8, 1995

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship

October 2, 1992

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980